1985
DOI: 10.1016/0360-3016(85)90156-7
|View full text |Cite
|
Sign up to set email alerts
|

Requirements for a treatment planning system for radioimmunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

1987
1987
2010
2010

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 54 publications
(14 citation statements)
references
References 20 publications
0
14
0
Order By: Relevance
“…To do this, it is necessary first to label the MoAb with a 1-ray emitting nuclide to determine the distribution within the body. 3,19 In this paper, we demonstrated our method of measurement and applied it to calculate the percentage of the injection dose per unit weight of the tumor, and of the liver and the bone marrow, which are thought to be critical organs during treatment.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…To do this, it is necessary first to label the MoAb with a 1-ray emitting nuclide to determine the distribution within the body. 3,19 In this paper, we demonstrated our method of measurement and applied it to calculate the percentage of the injection dose per unit weight of the tumor, and of the liver and the bone marrow, which are thought to be critical organs during treatment.…”
Section: Discussionmentioning
confidence: 99%
“…I /e Kr (3) where ,u and I are the linear attenuation coefficient and the path length in the absorber, respectively. However, it is not so easy to calculate the correction value for an actual human organ and tumor, because its shape is generally complex.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Accurate dose planning that estimates the therapeutic effect will therefore be necessary when developing radiopharmaceuticals with more precise targeting (Strand etal. 1986;Ljungberg and Strand 1988a, b;Zanzonico et al 1988;DeNardo et al 1989;Leichner et al 1990). The therapeutic activity can be estimated by administering a small 'diagnostic' amount of the radiopharmaceutical, or its analogue, and measuring the activity distribution in the target and in other important regions.…”
Section: Introductionmentioning
confidence: 99%